Scientists hunt for Eczema's origin in Baby's first blood
NCT ID NCT07316465
Summary
This study aims to understand if babies are born with 'self-attacking' antibodies that target their own skin cells, and if these antibodies are linked to developing eczema. Researchers will follow 500 newborns, some at high risk for eczema, for two years. They will check umbilical cord blood and follow up at 6, 12, and 24 months to see if these antibodies predict or influence eczema development.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel (VUB)
RECRUITINGJette, Brussels Capital, 1090, Belgium
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.